US may pay 3x more than EU for Moderna’s US-funded COVID shot

Enlarge / Moderna CEO Stephane Bancel during a Bloomberg Television interview on the closing day of the World Economic Forum in Davos, Switzerland, on May 26, 2022. Getty | Jason Alden

Compared with other countries, the US is again seeing exorbitant prices for a medicine—even one it helped develop.

In the current COVID-19 booster campaign, the Centers for Disease Control and Prevention is paying around $82 for each dose of Moderna’s 2023–2024 updated mRNA COVID-19 vaccine for its program to provide vaccine for the uninsured. That price is a little over three times the $26 per dose the federal government

→ Continue reading at Ars Technica

Related articles

Comments

Share article

Latest articles